DVDitte Vassard

Ditte Vassard

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Ditte Vassard has a total of 178 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Ethnic disparity in the use of ART treatment: a national register-based cross-sectional study among women in Denmark

    by A A Petersen, S S Østergaard, F N Kyhl, J Passet-Wittig, N Milewski, L Schmidt, D Vassard

    STUDY QUESTION: Is ethnic background among 18- to 45-year-old women associated with initiating ART treatment in Denmark? SUMMARY ANSWER: Results indicate ethnic disparity in the use of ART treatment, with immigrants and their descendants having lower odds of initiating ART treatment compared to women with Danish origin. WHAT IS KNOWN ALREADY: The use of fertility treatment has increased over the past decades. Ethnic disparity exists in the use of health care, but there is limited knowledge about the association between migrant origin and use of fertility treatment. Previous studies have shown that women with lower socioeconomic position (SEP) have lower odds of initiating ART treatment compared to women with higher SEP. Immigrants and their descendants often have lower SEP compared to the general population (i.e. non-migrants or natives), but specific mechanisms might be at play when residing and navigating in a new country and healthcare system. STUDY DESIGN, SIZE, DURATION: This is a national, register-based study based on a sample of the Danish National ART-Couple (DANAC II) cohort, a full population cohort encompassing men and women registered with a Danish residence and with birth year between 1948 and 2006. Women initiating ART treatment (IVF or ICSI) aged 18–45 years were identified in the Danish IVF Register from 1994 to 2017. According to the time of ART treatment women were included in the study and randomly age-matched with 10 untreated women in the untreated background population. The study population consisted of 676 355 women. PARTICIPANTS/MATERIALS, SETTING, METHODS: The probability of initiating ART treatment was compared across ethnic groups and examined in logistic regression analyses. Migration status and country of origin were used as proxies for ethnic groups in separate analysis. Age was accounted for by matching, and additional factors of interest such as SEP measures were classified as potential mediators and thus not included in the main analyses. MAIN RESULTS AND THE ROLE OF CHANCE: The study population consisted of 526 507 (78%) women of Danish origin, 142 656 (21%) immigrants, and 7192 (1%) descendants of immigrants. Among women of Danish origin 11% had initiated ART treatment compared to 5% of immigrants and 9% of descendants. Immigrants had 56% lower odds of receiving first ART treatment compared to women of Danish origin (odds ratio (OR) 0.44, CI 95% 0.43–0.45), while descendants had 22% lower odds compared to women of Danish origin (OR 0.78, CI 95% 0.72–0.84). Regarding the analysis examining country of origin, results showed that 3–4% of women originating from western countries had received first ART treatment compared to 6–8% of women originating from non-western countries. Women originating from western countries had between 65% and 78% lower odds for receiving first ART treatment compared to women of Danish origin. Odds of receiving ART treatment among women of non-western origin were between 34% and 47% lower compared to women of Danish origin. LIMITATIONS, REASONS FOR CAUTION: Information on the reason for infertility and desire to have children could have provided more insight into existing disparities. Data about the basis for residence could have provided information on reasons for immigration and duration of residence. WIDER IMPLICATIONS OF THE FINDINGS: Infertility and childlessness can have severe consequences for individuals and society, and equal access to fertility treatment is important, particularly in a universal welfare society. The results of this study indicate ethnic disparity in the use of ART treatment, and we encourage further research into the possible causes and barriers to initiate treatment. STUDY FUNDING/COMPETING INTEREST(S): The funding for the establishment of the Danish National ART-Couple II Cohort (DANAC II Cohort) was obtained from the Rosa Ebba Hansen Foundation. The authors have no conflicts of interest to declare. TRIAL REGISTRATION NUMBER: N/A.

  • Open Access

    Socioeconomic disparities in achieving a live birth after initiating ART treatment: a national register-based study among women in Denmark

    by Rikke B Uggerhøj, Andrea R Skaaning, Frederik N Kyhl, Lone Schmidt, Ditte Vassard

    STUDY QUESTION: How are educational level, labour market attachment, and income associated with achieving a live birth following ART treatment initiation among women in Denmark? SUMMARY ANSWER: Higher educational level, labour market attachment, and higher income were strongly associated with achieving a live birth after initiating ART treatment among women in Denmark. WHAT IS KNOWN ALREADY: During the study period 1994–2017, three ‘fresh’ IVF or ICSI treatments with hormonal stimulation were offered free of charge in public healthcare in Denmark, while additional ART treatments were self-financed in the private healthcare sector. Earlier research indicates that higher socioeconomic position (SEP) increases the probability of initiating ART treatment; however, knowledge about SEP and its relation to outcomes after ART treatment is limited. STUDY DESIGN, SIZE, DURATION: This is a national, register-based cohort study based on the Danish National ART-Couple (DANAC II) Cohort. Women initiating ART treatment during 1994–2017 were identified in the Danish IVF register and individually linked with data from sociodemographic registries and the Medical Birth Registry using the Danish Personal Identification number. The study population comprised 68 738 women who initiated ART. The women were followed until achieving a live birth, death, migration, or end of study (31/12/2017). The median follow-up time was between 1.3 and 1.9 years. PARTICIPANTS/MATERIALS, SETTINGS, METHODS: Women included in the analyses were aged 18–45 years. Overall associations between achieving a live birth after initiating ART treatment and educational level, labour market attachment, and income were examined and further stratified by nulliparity at baseline and age group. Hazard ratios (HRs) with confidence intervals (CIs) were estimated by Cox proportional hazards regression, and with adjustment for potential confounders including age and ethnicity. Live births refer to both treatment and non-treatment-related births. MAIN RESULTS AND THE ROLE OF CHANCE: Adjusted results showed that educational level, labour market attachment, and income significantly determined the probability of achieving a live birth after initiating ART treatment. HRs of achieving a live birth after initiating ART treatment increased stepwise with higher education and income level, respectively. Compared with primary school education, the highest HR was found among women with a research education (adjusted HR (aHR) = 3.02 [95% CI, 2.71; 3.35]). Unemployed women had the lowest HR of achieving a live birth after initiating ART treatment (aHR = 0.67 [95% CI, 0.64; 0.69]) compared to employed women. Women at the highest income level had two times higher HR (aHR = 2.00 [1.94; 2.06] of achieving a live birth after initiating ART compared to women at the lowest income level. Analyses of different age groups showed that higher SEP was associated with a live birth after ART treatment in all ages. The same consistency was found for both childless women and women who had a child or children prior to ART treatment. Analyses showed that women with higher SEP were more likely to continue ART treatment after unsuccessful attempts, which could explain the observed social inequality in achieving a live birth after ART treatment. LIMITATIONS, REASONS FOR CAUTION: The Danish IVF register did not register non-ART treatments (intrauterine inseminations) before 2007; thus, these treatments were not included. Whether the severity of infertility differs among SEP groups is unclear. Also, geographical distance to fertility clinics could have provided additional perspectives. WIDER IMPLICATIONS OF THE FINDINGS: Free access to fertility treatment in public healthcare should ideally provide equal access. Patients encounter barriers during treatment, and as shown, treatment success differs based on socioeconomic background. Difficulties encountered during treatment that challenge certain patients more than others based on their socioeconomic background need to be considered further. STUDY FUNDING/COMPETING INTEREST(S): No specific funding was achieved for this project. The authors have no conflicts of interest to declare. TRIAL REGISTRATION NUMBER: N/A


  • Open Access

    Visitation and stratification of help-seeking youth with mental health problems: a three-year follow-up study

    by Louise F. Madelaire, Martin K. Rimvall, Pia Jeppesen, Ditte Vassard

    Purpose: Stage-based stepped care approaches aim to address gaps between prevention and specialized treatment for mental disorders by directing proportionate interventions in a timely manner. We examined whether increasing stage level, assigned after visitation of youths seeking help in a primary care municipal setting, reflected an increased risk of adverse outcomes after three years. Methods: Help-seeking youths (6–16 years) were stratified into three stages of developmental psychopathology based on the severity and impact of parent- and self-reported mental health problems corresponding to following levels of need for actions: low-intensity intervention (Stage 1); moderate-intensity preventive intervention, (Stage 2); suggested referral to specialized mental health services (Stage 3). Information on diagnosed mental disorders and prescription of psychotropic medications over the following 3.6 years (median follow-up) was retrieved from the Danish National Registries. Outcomes were compared across the staged groups and compared to an age-matched population-based comparison group ( N = 16,980, reference group). Results: Among 566 help-seeking youths, n = 74 (13%) were stratified to Stage 1, n = 436 (77%) to Stage 2, and n = 56 (10%) to Stage 3. Hazard ratios (95% confidence intervals) of receiving a psychiatric diagnosis during three years of follow-up were 3.2 (1.9–5.2) for Stage 1, 3.9 (3.2–4.8) for Stage 2, and 9.0 (6.2–13.3) for Stage 3. Similar stepwise increasing estimates were present regarding use of psychotropic medications, school absence and notifications of concern. Conclusion: Increased risk of later psychiatric morbidity with increased stage level supports the clinical utility of the stage-based stratification-model for early detection and treatment in the primary care sector.

  • Open Access

    Outcome and cost‐effectiveness of transdiagnostic cognitive behavioral therapy compared with management as usual for youth with common mental health problems: Long‐term results from the Mind‐My‐Mind randomized trial

    by Ditte Vassard, Martin Køster Rimvall, Rasmus Trap Wolf, Robin Christensen, Sabrina M. Nielsen, Kerstin Jessica Plessen, Frank Verhulst, Niels Bilenberg, Per Hove Thomsen, Mikael Thastum, et al.

    Background: Credible long‐term outcomes from randomized trials evaluating the effectiveness and cost‐effectiveness of preventive programs for mental health problems are needed. We compared long‐term effects of the Mind My Mind (MMM) transdiagnostic cognitive behavioral therapy (CBT) program to management as usual (MAU). Methods: The study was a pragmatic, multisite, randomized superiority trial (2017–2019) involving youths aged 6–16 years with anxiety, depressive symptoms, and/or behavioral disturbances, recruited through family self‐referral. The MMM intervention included 9–13 weekly CBT sessions. The primary outcome was change from baseline in parent‐reported impact of mental health problems at 3‐year follow‐up post‐randomization using the Strengths and Difficulties Questionnaire (SDQ) impact scale. Register‐based outcomes tracked youths' psychiatric diagnoses in mental health services. To assess cost‐effectiveness, we calculated the incremental costs and incremental quality‐adjusted life years (QALYs). All primary analyses followed the intention‐to‐treat (ITT) approach. Clinical trials registration: ID NCT04804917. Results: Among 396 youths randomized (baseline mean [ SD ] age, 10.3 [2.4] years; 52.0% boys; MMM n = 197, MAU n = 199), the 3‐year follow‐up (median 167 weeks; range 124–203 weeks) primary outcome data were available in 69.0% and 59.3%, respectively. The decrease in SDQ‐impact‐score from baseline to 3‐year follow‐up (4.12→1.79 points [MMM] and 4.21→1.85 [MAU]) was similar (between‐group difference, 0.06 [95% CI −0.41 to 0.52]; p = .81). An equal proportion (25%) of youths in MMM and MAU were diagnosed with any mental disorder during follow‐up (HR 1.01, 95% CI 0.68–1.50). Total costs over the intervention period were higher in the MMM group (incremental costs 3,014 Euros [95% CI: 2.174–3.855]). Cost‐effectiveness analyses favored MMM: QALY net gain 0.121 (95% CI 0.045–0.196); the cost‐effectiveness ratio was 24,789 Euro/QALY. Conclusions: Although MMM was potentially cost‐effective, the beneficial effects diminished over 3 years post‐treatment. The findings highlight the need for strategies to sustain long‐term effects.


  • Open Access

    Risk of placenta previa in assisted reproductive technology: A Nordic population study with sibling analyses

    by Eirik Landsverk, Kjersti Westvik-Johari, Ulla-Britt Wennerholm, Christina Bergh, Frederik Kyhl, Anne Lærke Spangmose, Ditte Vassard, Anja Pinborg, Kristiina Rönö, Mika Gissler, et al.

    Background: A higher risk of placenta previa after assisted reproductive technology (ART) is well established. The underlying mechanisms are poorly understood, but may relate to embryo culture duration, cryopreservation, and cause of infertility. Within-mother analyses, where each woman is her own control (i.e., sibling design), help disentangle treatment contributions from maternal confounders that are stable between pregnancies. We aimed to investigate the risk of placenta previa in pregnancies achieved after ART according to embryo culture duration, cryopreservation, and infertility factors while accounting for stable maternal factors using within-mother analyses. Methods and findings: We used linked nationwide registry data from Denmark (1994 to 2014), Finland (1990 to 2014), Norway (1988 to 2015), and Sweden (1988 to 2015). All women who gave their first birth during the study period at age 20 years or older were eligible and contributed up to 4 deliveries (singleton or multifetal) occurring between 22 and 44 weeks of gestation, excluding deliveries where maternal age exceeded 45 years. We used multilevel logistic regression to compare risk of placenta previa after ART (n = 139,694 deliveries) versus natural conception (n = 5,614,512 deliveries), both at the population level and within mothers, adjusting for year of delivery, maternal age, parity, and country. We categorized ART according to culture duration, embryo cryopreservation, and infertility factors. Population level risk of placenta previa was higher for ART versus natural conception (odds ratio [OR], 4.16; 95% confidence interval [CI], 3.96–4.37). Controlling for stable maternal factors, the association attenuated, but risk remained higher for ART versus natural conception (OR within mothers, 2.64; 95% CI, 2.31–3.02). Compared to naturally conceived, a larger difference in risk was seen for pregnancies from fresh embryos than for pregnancies from frozen embryos. Further categorization by culture duration showed the largest risk difference after fresh blastocyst transfer, and the smallest after frozen cleavage stage embryo transfer, which persisted in sensitivity analyses (including restriction to singletons). When stratified according to infertility factors at the population level, women with endometriosis conceiving by ART had the highest risk of placenta previa (OR, 9.35; 95% CI, 8.50–10.29), whereas women with polycystic ovary syndrome (PCOS) conceiving by ART had the lowest risk (OR, 1.52; 95% CI, 1.12–2.09), compared to natural conception. Within mothers, we found a higher risk of placenta previa after ART compared to natural conception for women with endometriosis (OR, 2.08; 95% CI, 1.50–2.90), but not for women with PCOS (OR, 0.88; 95% CI, 0.41–1.89 [unadjusted due to sparse data]). However, within-mother analyses are restricted to multiparous women with deliveries after different conception methods. Therefore, findings from these analyses might not generalize to all women undergoing ART. Conclusions: The risk of placenta previa in pregnancies conceived by ART differed by embryo culture duration, cryopreservation, and underlying infertility. The highest risk was seen after fresh embryo transfer and especially fresh blastocyst transfer. Women with endometriosis had a higher risk than women with other infertility factors, and within mothers, their risk was higher after ART than after natural conception. Identifying the responsible mechanisms might provide opportunities for prevention.


  • Open Access

    Permanently infertile couples and family building—a cross-sectional survey in Denmark

    by M Tanderup, D Vassard, B B Nielsen, A Pande, C Kroløkke, P Humaidan, L Schmidt

    STUDY QUESTION: Which decision-making factors influence family building among permanently infertile couples? SUMMARY ANSWER: Ethical, legal, and financial considerations outweigh genetic relatedness in decision-making, favouring domestic gestational surrogacy, if this were possible, over international options. WHAT IS KNOWN ALREADY: Permanent infertility affects 4–5% of people in the fertile age. Their family-building options include adoption, surrogacy, uterus transplantation, foster care, and intentional multiple parenthood. However, in most countries, including Denmark, legal barriers constrain these methods due to surrogacy restrictions, suspended international adoptions, and the experimental status of uterus transplantation. Despite existing research on surrogacy, adoption, and specific causes of permanent infertility, a significant gap remains in our understanding of how couples with permanent infertility make family-building decisions within these limited frameworks. STUDY DESIGN, SIZE, DURATION: This cross-sectional study with 150 permanently infertile Danish participants was conducted from June to November 2023 using an online questionnaire. Multiple strategies, such as online forums, fertility clinics, hospital departments, and snowballing, were used to recruit a diverse sample. PARTICIPANTS/MATERIALS, SETTING, METHODS: The study included couples aged 26–50 years facing permanent infertility due to the following primary causes: women without a uterus (15%), women with a non-functional uterus (47%) or women for whom pregnancy would be life-threatening (9%), male couples (16%), transgender partner couples (2%), and other causes (11%). The survey collected data on demographics, reproductive history, family-building choices, and communication strategies. Closed questions were analysed using descriptive statistics. MAIN RESULTS AND THE ROLE OF CHANCE: Among 150 respondents, 41% had used transnational surrogacy, 27% adoption, 14% chose to remain childless, and 19% were undecided. Critical factors on family-building decisions were ethical, legal, and financial concerns which ranked higher than genetic relatedness. Despite the complexity of family building, most participants were open about their child’s origin and received social support. If all family-building methods were legal and available in Denmark, domestic gestational surrogacy would be the preferred method, with uterus transplantation and remaining childless being least popular. LIMITATIONS, REASONS FOR CAUTION: The sample size is relatively small, despite the use of a variety of recruitment strategies. Nevertheless, this has ensured a diverse cohort representing the different reasons for infertility and family-building choices. It is important to note that the strategies may have favoured individuals achieving parenthood. WIDER IMPLICATIONS OF THE FINDINGS: The finding of our study reveals a notable gap between available family-building options in Denmark and the preferences of couples facing permanent infertility. These insights could be instrumental for organizations reviewing and developing family-building frameworks. Furthermore, for healthcare professionals guiding couples experiencing infertility issues in their attempts to build a family, an understanding of these preferences is essential to facilitate informed decisions about their future family plans. STUDY FUNDING/COMPETING INTEREST(S): The project was financed by the Independent Research Fund Denmark. The authors have no conflict of interest to declare. TRIAL REGISTRATION NUMBER: N/A.

  • Open Access

    Effect modification of an effective transdiagnostic cognitive behavioral psychotherapy in youths with common mental health problems: Secondary analyses of the randomized mind-my-mind trial

    by Martin Køster Rimvall, Ditte Vassard, Sabrina Mai Nielsen, Rasmus Trap Wolf, Kerstin Jessica Plessen, Niels Bilenberg, Per Hove Thomsen, Mikael Thastum, Simon-Peter Neumer, Louise Berg Puggaard, et al.


  • Social disparities in the use of ART treatment: a national register-based cross-sectional study among women in Denmark

    by Louise Ayoe Sparvath Brautsch, Ida Voss, Lone Schmidt, Ditte Vassard

    STUDY QUESTION: How are educational level, labor market attachment and income associated with receiving a first ART treatment in either the public or private healthcare sector among women in Denmark?SUMMARY ANSWER: Higher educational level and income as well as labor market attachment were associated with higher probability of initiating ART treatment at public and private fertility clinics among women in Denmark.WHAT IS KNOWN ALREADY: Infertility is common in populations worldwide, and the approach to this issue differs between societies and healthcare systems. In the public Danish healthcare system, ART treatment is free of charge, and the direct cost for patients is therefore low. In the private healthcare sector in Denmark, ART treatment is self-financed. There is limited knowledge about the association between socioeconomic factors and seeking ART treatment, although previous studies have indicated that higher socioeconomic status is associated with seeking ART treatment.STUDY DESIGN, SIZE, DURATION: Women undergoing ART treatment during 1994–2016 registered in the Danish IVF register were individually linked with data from sociodemographic population registers using the Danish Personal Identification number. The study population consisted of 69 018 women treated with ART and 670 713 age-matched comparison women from the background population with no previous history of ART treatment.PARTICIPANTS/MATERIALS, SETTING, METHODS: The women included in the analyses were aged 18–45 years. The associations between attained educational level, labor market attachment and income and receiving a first ART treatment attempt were investigated for women either initiating treatment in the public sector or in the private sector, respectively. Information on age and origin was included as potential confounders, and odds ratios (ORs) were estimated in logistic regression models. In addition, analyses were stratified by age group to investigate potential differences across the age span.MAIN RESULTS AND THE ROLE OF CHANCE: Adjusted results showed increased odds of receiving a first ART treatment in either the public or private sector among women with a higher educational level. Furthermore, women in employment were more likely to receive a first ART treatment in the public or private sector compared to women outside the workforce. The odds of receiving a first ART treatment increased with increasing income level. Surprisingly, income level had a greater impact on the odds of receiving a first ART treatment in the public sector than in the private sector. Women in the highest income group had 10 times higher odds of receiving a first ART treatment in the public sector (OR: 10.53 95% CI: 10.13, 10.95) compared to women in the lowest income group. Sub-analyses in different age groups showed significant associations between ART treatment and income level and labor market attachment in all age groups.LIMITATIONS, REASONS FOR CAUTION: Our study does not include non-ART treatments, as the national IVF register did not register these types of fertility treatments before 2007.WIDER IMPLICATIONS OF THE FINDINGS: In Denmark, there is equal access to medically assisted reproduction treatment in the publicly funded healthcare system, and since there is no social inequality in the prevalence of infertility, social inequality in the use of ART treatment would not be expected as such. However, our results show that social inequality is found for a first ART treatment attempt across publicly and privately funded ART treatment across the socioeconomic indicators, educational level, labor market attachment and income.STUDY FUNDING/COMPETING INTEREST(S): The funding for the establishment of the Danish National ART-Couple II Cohort (DANAC II Cohort) was obtained from the Rosa Ebba Hansen Foundation. The authors have no conflict of interest to declare.TRIAL REGISTRATION NUMBER: N/A.


  • Open Access

    Infertility, pregnancy loss and assisted reproduction in women with asthma: a population-based cohort study

    by Anna Jöud, Emma Nilsson-Condori, Lone Schmidt, Søren Ziebe, Ditte Vassard, Kristina Mattsson

    STUDY QUESTION: Is the chance of childbirth, and risk of infertility, pregnancy loss and need for assisted reproduction different for women with asthma compared to women without asthma? SUMMARY ANSWER: Women with asthma had comparable chances of giving birth compared to the reference population, however, their risk of both infertility and pregnancy loss, as well their need for medically assisted reproduction, was higher. WHAT IS KNOWN ALREADY: Reproductive dysfunction has been reported among women with asthma, including longer time to pregnancy, increased risk of pregnancy loss and a higher need of medically assisted reproduction, but their risk of clinical infertility is unknown. STUDY DESIGN, SIZE, DURATION: This longitudinal register-based cohort study included all women with a healthcare visit for delivery, infertility, pregnancy loss or induced abortion in the southernmost county in Sweden, over the last 20 years. PARTICIPANTS/MATERIALS, SETTING, METHODS: Using the Skåne Healthcare Register, we identified all women aged 15–45 between 1998 and 2019, who received a diagnosis of asthma before their first reproductive outcome (n = 6445). Chance of childbirth and risk of infertility, pregnancy loss and assisted reproduction were compared to a healthcare seeking population of women without any asthma (n = 200 248), using modified Poisson regressions. MAIN RESULTS AND THE ROLE OF CHANCE: The chance of childbirth was not different between women with asthma versus those without, adjusted risk ratio (aRR) = 1.02, 95% CI: 1.01–1.03. The risk of seeking care for infertility was increased, aRR = 1.29, 95% CI: 1.21–1.39, and women with asthma more often needed assisted reproduction aRR = 1.34 95% CI: 1.18–1.52. The risk of suffering a pregnancy loss was higher, aRR = 1.21, 95% CI: 1.15–1.28, and induced abortions were more common, aRR = 1.15, 95% CI: 1.11–1.20, among women with asthma. LIMITATIONS, REASONS FOR CAUTION: The study was an observational study based on healthcare visits and lacked detailed anthropometric data, thus residual confounding cannot be excluded. Only women with a healthcare visit for a reproductive outcome were included, which cannot be translated into pregnancy intention. A misclassification, presumed to be non-differential, may arise from an incorrect or missing diagnosis of asthma or female infertility, biasing the results towards the null. WIDER IMPLICATIONS OF THE FINDINGS: This study points towards reproductive dysfunction associated with asthma, specifically in regards to the ability to maintain a pregnancy and the risk of needing medically assisted reproduction following clinical infertility, but reassuringly the chance of subsequently giving birth was not lower for these women. STUDY FUNDING/COMPETING INTEREST(S): This article is part of the ReproUnion collaborative study, co-financed by EU Interreg ÖKS, Capital Region of Denmark, Region Skåne and Ferring Pharmaceuticals. The authors have no competing interests to disclose. TRIAL REGISTRATION NUMBER: N/A.


  • Assisted reproductive technology treatment and risk of breast cancer: a population-based cohort study

    by D Vassard, A Pinborg, M Kamper-Jørgensen, J Lyng Forman, C H Glazer, N Kroman, L Schmidt

    STUDY QUESTION: Is there an increased risk of breast cancer among women after ART treatment including ovarian hormone stimulation? SUMMARY ANSWER: The risk of breast cancer was slightly increased among women after ART treatment compared to age-matched, untreated women in the background population, and the risk was further increased among women initiating ART treatment when aged 40+ years. WHAT IS KNOWN ALREADY: The majority of breast cancer cases are sensitive to oestrogen, and ovarian hormone stimulation has been suggested to increase the risk of breast cancer by influencing endogenous oestrogen levels. Previous studies on ART treatment and breast cancer have varied in their findings, but several studies have small sample sizes or lack follow-up time and/or confounder adjustment. Recent childbirth, nulliparity and higher socio-economic status are breast cancer risk factors and the latter two are also associated with initiating ART treatment. STUDY DESIGN, SIZE, DURATION: The Danish National ART-Couple II (DANAC II) cohort includes women treated with ART at public and private fertility clinics in 1994–2016. PARTICIPANTS/MATERIALS, SETTING, METHODS: Women with no cancer prior to ART treatment were included (n = 61 579). Women from the background population with similar age and no prior history of ART treatment were randomly selected as comparisons (n = 579 760). The baseline mean age was 33.1 years (range 18–46 years). Results are presented as hazard ratios (HRs) with corresponding CIs. MAIN RESULTS AND THE ROLE OF CHANCE: During follow-up (median 9.69 years among ART-treated and 9.28 years among untreated), 5861 women were diagnosed with breast cancer, 695 among ART-treated and 5166 among untreated women (1.1% versus 0.9%, P < 0.0001). Using Cox regression analyses adjusted for nulliparity, educational level, partnership status, year, maternal breast cancer and age, the risk of breast cancer was slightly increased among women treated with ART (HR 1.14, 95% CI 1.12–1.16). All causes of infertility were slightly associated with breast cancer risk after ART treatment. The risk of breast cancer increased with higher age at ART treatment initiation and was highest among women initiating treatment at age 40+ years (HR 1.37, 95% CI 1.29–1.45). When comparing women with a first birth at age 40+ years with or without ART treatment, the increased risk among women treated with ART persisted (HR 1.51, 95% CI 1.09–2.08). LIMITATIONS, REASONS FOR CAUTION: Although this study is based on a large, national cohort of women, more research with sufficient power and confounder adjustment is needed, particularly in cohorts with a broad age representation. WIDER IMPLICATIONS OF THE FINDINGS: An increased risk of breast cancer associated with a higher age at ART treatment initiation has been shown. Ovarian stimulation may increase the risk of breast cancer among women initiating ART treatment when aged 40+ years. Age-related vulnerability to hormone exposure or higher hormone doses during ART treatment may explain the increased risk. STUDY FUNDING/COMPETING INTEREST(S): This work was supported by a PhD grant to D.V. from the Faculty of Health and Medical Sciences, University of Copenhagen, Denmark. Funding for establishing the DANAC II cohort was received from the Ebba Rosa Hansen Foundation. The authors report no conflict of interest. TRIAL REGISTRATION NUMBER: N/A.